XML 37 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Transactions (Tables)
3 Months Ended
Mar. 31, 2017
Organizational Transactions [Abstract]  
Schedule of allocation of purchase price
The purchase price was allocated to the assets acquired based on their fair values as of February 1, 2016, as follows (in thousands):

Purchase Consideration
 
Fair value of Class A common stock issued
$
10,450

Fair value of contingent consideration
7,750

Total consideration
$
18,200

 
 
Tangible assets acquired
 
Prepaid asset
$
6,900

 
 
Goodwill
11,300

Net assets acquired
$
18,200

The purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values as of November 1, 2016, as follows (in thousands):

Purchase consideration:
 
Fair value of Class A common stock issued
$
9,864

Cash for settlement of software license
7,000

Cash
17,481

Total consideration
$
34,345

 
 
Tangible assets acquired:
 
Receivables
$
624

Prepaid expenses and other current assets
272

Property and equipment
1,065

Other non-current assets
9

 
 
Identifiable intangible assets acquired:
 
Customer relationships
7,000

Technology
2,500

 
 
Liabilities assumed:
 
Accounts payable
429

Accrued liabilities
1,204

Accrued compensation and employee benefits
605

Deferred revenue
44

 
 
Goodwill
25,157

Net assets acquired
$
34,345

Schedule of net assets acquired
The purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values as of October 3, 2016. During the three months ended March 31, 2017, the Company recorded an adjustment to deferred revenue. The purchase price allocation, as previously determined, the measurement period adjustment and the purchase price allocation, as revised, are as follows (in thousands):
 
 
 
 
Measurement
 
 
 
As Previously
Period
 
 
 
Determined
Adjustment
As Revised
 
Purchase consideration:
 
 
 
 
 
 
 
 
Fair value of Class A common stock issued
 
$
159,614

 
 
$
—

 
 
$
159,614

Fair value of contingent consideration
 
2,620

 
 
—

 
 
2,620

Cash
 
54,799

 
 
—

 
 
54,799

Total consideration
 
$
217,033

 
 
 
 
 
$
217,033

 
 
 
 
 
 
 
 
 
Tangible assets acquired:
 
 
 
 
 
 
 
 
Restricted cash
 
$
1,829

 
 
$
—

 
 
$
1,829

Accounts Receivable
 
8,587

 
 
—

 
 
8,587

Prepaid expenses and other current assets
 
3,465

 
 
—

 
 
3,465

Property and equipment
 
6,241

 
 
—

 
 
6,241

Other non-current assets
 
313

 
 
—

 
 
313

 
 
 
 
 
 
 
 
 
Favorable leases assumed (net of unfavorable leases)
 
4,323

 
 
—

 
 
4,323

 
 
 
 
 
 
 
 
 
Identifiable intangible assets acquired:
 
 
 
 
 
 
 
 
Customer relationships
 
69,000

 
 
—

 
 
69,000

Technology
 
18,000

 
 
—

 
 
18,000

 
 
 
 
 
 
 
 
 
Liabilities assumed:
 
 
 
 
 
 
 
 
Accounts payable
 
5,703

 
 
—

 
 
5,703

Accrued liabilities
 
3,865

 
 
—

 
 
3,865

Accrued compensation and employee benefits
 
9,200

 
 
—

 
 
9,200

Deferred revenue
 
2,022

 
 
640

 
 
2,662

Other long-term liabilities
 
2,328

 
 
—

 
 
2,328

Net deferred tax liabilities
 
13,316

 
 
—

 
 
13,316

 
 
 
 
 
 
 
 
 
Goodwill
 
141,709

 
 
640

 
 
142,349

Net assets acquired
 
$
217,033

 
 
 
 
 
$
217,033

Business acquisition, pro forma information
The pro forma adjustments were based on available information and assumptions that the Company believes are reasonable to reflect the impact of these transactions on the Company’s historical financial information on a pro forma basis (in thousands, except per share data).
 
For the Three
 
Months Ended
 
 
March 31,
 
 
 
2016
 
Revenue
 
$
81,326

 
Net income (loss)
 
(177,620
)
 
Net income (loss) attributable
 
 
 
to non-controlling interests
 
(46,022
)
 
Net income (loss) attributable
 
 
 
to Evolent Health, Inc.
 
(131,598
)
 
 
 
 
 
Net income (loss) available to
 
 
 
common shareholders:
 
 
 
Basic
 
(2.63
)
 
Diluted
 
(2.63
)